Copyright Reports & Markets. All rights reserved.

Global Chronic Obstructive Pulmonary Disease Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Chronic Obstructive Pulmonary Disease Drugs Market Overview

      • 1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease Drugs
      • 1.2 Chronic Obstructive Pulmonary Disease Drugs Segment by Type
        • 1.2.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Inhalers
        • 1.2.3 Nebulizers
      • 1.3 Chronic Obstructive Pulmonary Disease Drugs Segment by Application
        • 1.3.1 Chronic Obstructive Pulmonary Disease Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Emphysema
        • 1.3.3 Chronic Bronchitis
        • 1.3.4 Refractory Asthma
        • 1.3.5 Others
      • 1.4 Global Chronic Obstructive Pulmonary Disease Drugs Market by Region
        • 1.4.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Chronic Obstructive Pulmonary Disease Drugs Market Size
        • 1.5.1 Global Chronic Obstructive Pulmonary Disease Drugs Revenue (2014-2025)
        • 1.5.2 Global Chronic Obstructive Pulmonary Disease Drugs Production (2014-2025)

      2 Global Chronic Obstructive Pulmonary Disease Drugs Market Competition by Manufacturers

      • 2.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Chronic Obstructive Pulmonary Disease Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Chronic Obstructive Pulmonary Disease Drugs Production Sites, Area Served, Product Types
      • 2.5 Chronic Obstructive Pulmonary Disease Drugs Market Competitive Situation and Trends
        • 2.5.1 Chronic Obstructive Pulmonary Disease Drugs Market Concentration Rate
        • 2.5.2 Chronic Obstructive Pulmonary Disease Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Chronic Obstructive Pulmonary Disease Drugs Production Market Share by Regions

      • 3.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Market Share by Regions
      • 3.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Chronic Obstructive Pulmonary Disease Drugs Production
        • 3.4.1 North America Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Chronic Obstructive Pulmonary Disease Drugs Production
        • 3.5.1 Europe Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Chronic Obstructive Pulmonary Disease Drugs Production (2014-2019)
        • 3.6.1 China Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Chronic Obstructive Pulmonary Disease Drugs Production (2014-2019)
        • 3.7.1 Japan Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Chronic Obstructive Pulmonary Disease Drugs Consumption by Regions

      • 4.1 Global Chronic Obstructive Pulmonary Disease Drugs Consumption by Regions
      • 4.2 North America Chronic Obstructive Pulmonary Disease Drugs Consumption (2014-2019)
      • 4.3 Europe Chronic Obstructive Pulmonary Disease Drugs Consumption (2014-2019)
      • 4.4 China Chronic Obstructive Pulmonary Disease Drugs Consumption (2014-2019)
      • 4.5 Japan Chronic Obstructive Pulmonary Disease Drugs Consumption (2014-2019)

      5 Global Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Chronic Obstructive Pulmonary Disease Drugs Price by Type (2014-2019)
      • 5.4 Global Chronic Obstructive Pulmonary Disease Drugs Production Growth by Type (2014-2019)

      6 Global Chronic Obstructive Pulmonary Disease Drugs Market Analysis by Applications

      • 6.1 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Chronic Obstructive Pulmonary Disease Drugs Business

      • 7.1 AstraZeneca
        • 7.1.1 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.1.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Boehringer Ingelheim
        • 7.2.1 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.2.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.2.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 GSK
        • 7.3.1 GSK Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.3.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.3.3 GSK Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Novartis
        • 7.4.1 Novartis Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.4.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.4.3 Novartis Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Teva Pharmaceuticals
        • 7.5.1 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.5.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.5.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Ache Laboratorios Farmaceuticos
        • 7.6.1 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.6.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.6.3 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Almirall
        • 7.7.1 Almirall Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.7.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.7.3 Almirall Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Aquinox Pharmaceuticals
        • 7.8.1 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.8.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.8.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Ario Pharma
        • 7.9.1 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.9.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.9.3 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Asmacure
        • 7.10.1 Asmacure Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
        • 7.10.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
        • 7.10.3 Asmacure Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Astellas Pharma
      • 7.12 BioMarck Pharmaceuticals

      8 Chronic Obstructive Pulmonary Disease Drugs Manufacturing Cost Analysis

      • 8.1 Chronic Obstructive Pulmonary Disease Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease Drugs
      • 8.4 Chronic Obstructive Pulmonary Disease Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Chronic Obstructive Pulmonary Disease Drugs Distributors List
      • 9.3 Chronic Obstructive Pulmonary Disease Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Chronic Obstructive Pulmonary Disease Drugs Market Forecast

      • 11.1 Global Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast
        • 11.1.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Chronic Obstructive Pulmonary Disease Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Chronic Obstructive Pulmonary Disease Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Chronic Obstructive Pulmonary Disease Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Chronic obstructive pulmonary disease ( COPD ) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
        The inhalers segment dominated the global COPD drugs market

        The global Chronic Obstructive Pulmonary Disease Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Chronic Obstructive Pulmonary Disease Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chronic Obstructive Pulmonary Disease Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        AstraZeneca
        Boehringer Ingelheim
        GSK
        Novartis
        Teva Pharmaceuticals
        Ache Laboratorios Farmaceuticos
        Almirall
        Aquinox Pharmaceuticals
        Ario Pharma
        Asmacure
        Astellas Pharma
        BioMarck Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Inhalers
        Nebulizers

        Segment by Application
        Emphysema
        Chronic Bronchitis
        Refractory Asthma
        Others

        Buy now